サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1763167

軟骨変性治療の世界市場

Cartilage Degeneration Therapy

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
軟骨変性治療の世界市場
出版日: 2025年07月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

軟骨変性治療の世界市場は2030年までに209億米ドルに達する見込み

2024年に150億米ドルと推定される軟骨変性治療の世界市場は、2024年から2030年にかけてCAGR 5.6%で成長し、2030年には209億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである関節置換術は、CAGR 6.3%を記録し、分析期間終了時には77億米ドルに達する見込みです。軟骨形成術セグメントの成長率は、分析期間でCAGR 5.9％と推定されます。

米国市場は42億米ドルと推定、中国はCAGR5.4％で成長予測

米国の軟骨変性治療市場は2024年に42億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに33億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ5.2%と4.7%と予測されています。欧州では、ドイツがCAGR 5.3%で成長すると予測されています。

世界の軟骨変性治療市場- 主要動向と促進要因のまとめ

なぜ整形外科で軟骨変性治療の需要が増加しているのか？

軟骨変性治療の需要が整形外科で増加しているのは、変形性関節症、スポーツ障害、加齢による軟骨の摩耗など、関節障害の有病率が増加しているためです。痛み、可動性の低下、関節機能障害につながる軟骨の変性は、特に高齢化した人口の間で、世界中で何百万人もが罹患する一般的な問題です。再生医療、細胞療法、外科的介入を含む治療法は、関節機能を回復させ、痛みを軽減させる解決策を提供するものとして支持を集めています。人工関節置換術を遅らせる、あるいは回避するための治療を求める人が増える中、軟骨再生・保存療法は整形外科治療の重要な側面となりつつあります。

再生医療の進歩は、軟骨変性治療をどのように変えるのか？

再生医療の進歩は、幹細胞治療、多血小板血漿（PRP）、組織工学などの革新的なソリューションを提供することで、軟骨変性治療の分野に変革をもたらしつつあります。例えば幹細胞治療は、間葉系幹細胞を用いて損傷した軟骨を再生させるもので、従来の外科手術に代わる低侵襲な治療法です。組織工学的な足場や生体材料は、軟骨の修復をサポートし、新しい組織の成長を促すために開発されています。このような再生技術の進歩は、根本的な変性に対処するだけでなく、長期的な回復を促進し、患者の転帰を改善する可能性を提供し、軟骨関連疾患の治療におけるゲームチェンジャーとなっています。

高齢化人口の増加は軟骨変性治療市場でどのような役割を果たしているか？

高齢者は変形性関節症などの退行性関節疾患にかかりやすいため、高齢化人口の増加は軟骨変性治療市場の重要な促進要因です。平均寿命が延びるにつれて、関節に関連する疾患の有病率は上昇すると予想され、関節機能を維持し、生活の質を向上させる治療法に対する需要の高まりにつながっています。さらに、衝撃の大きいスポーツや身体活動に従事する若年層も、軟骨の損傷に対処する治療に対する需要を高めています。その結果、痛みを和らげ、運動機能を向上させ、人工関節置換術の必要性を遅らせる治療法が、世界のヘルスケア分野で脚光を浴びています。

軟骨変性治療市場の成長はいくつかの要因によってもたらされる

軟骨変性治療市場の成長は、変形性関節症やスポーツ関連傷害の発生率の上昇、再生医療の進歩、低侵襲治療への注目の高まりなど、いくつかの要因によって牽引されています。高齢化社会は、非外科的治療の選択肢に対する意識の高まりと相まって、関節の健康を回復させる革新的な治療に対する需要を煽っています。また、細胞ベース治療、組織工学、バイオマテリアルの技術的進歩により、軟骨変性に悩む患者が利用できる治療選択肢の幅も広がっています。効果的な関節温存療法のニーズが高まるにつれ、軟骨変性治療市場は世界的に大きな成長が見込まれています。

セグメント

用途（膝関節、股関節、その他の用途）、タイプ（人工関節置換術、軟骨移植術、骨軟骨移植術、マイクロフラクチャー、半月板移植術、細胞ベースの軟骨表面置換術、自己軟骨細胞移植術、その他のタイプ）

調査対象企業の例

  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • Ed. Geistlich Sohne AG（Geistlich Group）
  • Huntington Hospital
  • J&J MedTech
  • Smith & Nephew Plc
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16255

Global Cartilage Degeneration Therapy Market to Reach US$20.9 Billion by 2030

The global market for Cartilage Degeneration Therapy estimated at US$15.0 Billion in the year 2024, is expected to reach US$20.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Joint Replacements, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$7.7 Billion by the end of the analysis period. Growth in the Chondroplasty segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.2 Billion While China is Forecast to Grow at 5.4% CAGR

The Cartilage Degeneration Therapy market in the U.S. is estimated at US$4.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 5.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Cartilage Degeneration Therapy Market - Key Trends & Drivers Summarized

Why Is the Demand for Cartilage Degeneration Therapy Increasing in Orthopedics?

The demand for cartilage degeneration therapy is rising in orthopedics due to the increasing prevalence of joint disorders such as osteoarthritis, sports injuries, and age-related cartilage wear. Cartilage degeneration, which leads to pain, reduced mobility, and joint dysfunction, is a common issue that affects millions worldwide, especially among aging populations. Therapy options, including regenerative medicine, cell-based therapies, and surgical interventions, are gaining traction as they offer solutions to restore joint function and reduce pain. As more people seek treatments to delay or avoid joint replacement surgery, cartilage regeneration and preservation therapies are becoming a crucial aspect of orthopedic care.

How Are Advances in Regenerative Medicine Transforming Cartilage Degeneration Therapy?

Advances in regenerative medicine are transforming the field of cartilage degeneration therapy by providing innovative solutions such as stem cell therapy, platelet-rich plasma (PRP), and tissue engineering. Stem cell therapy, for example, involves the use of mesenchymal stem cells to regenerate damaged cartilage, offering a minimally invasive alternative to traditional surgery. Tissue-engineered scaffolds and biomaterials are being developed to support cartilage repair and encourage the growth of new tissue. These advancements in regenerative techniques not only address the underlying degeneration but also offer the potential to enhance long-term recovery and improve patient outcomes, making them a game-changer in the treatment of cartilage-related disorders.

What Role Does the Growing Aging Population Play in the Cartilage Degeneration Therapy Market?

The growing aging population is a significant driver of the cartilage degeneration therapy market, as elderly individuals are more prone to degenerative joint conditions such as osteoarthritis. As life expectancy increases, the prevalence of joint-related disorders is expected to rise, leading to a higher demand for therapies that can preserve joint function and improve quality of life. Additionally, younger populations engaged in high-impact sports or physical activities are also contributing to the demand for treatments that address cartilage damage. As a result, therapies that provide pain relief, improve mobility, and delay the need for joint replacement are gaining prominence in the global healthcare landscape.

The Growth in the Cartilage Degeneration Therapy Market Is Driven by Several Factors

The growth in the cartilage degeneration therapy market is driven by several factors, including the rising incidence of osteoarthritis and sports-related injuries, advancements in regenerative medicine, and the growing focus on minimally invasive treatments. The aging population, combined with the increased awareness of non-surgical treatment options, is fueling demand for innovative therapies that restore joint health. Technological advancements in cell-based therapies, tissue engineering, and biomaterials are also expanding the range of treatment options available for patients suffering from cartilage degeneration. As the need for effective joint preservation therapies increases, the cartilage degeneration therapy market is expected to experience significant growth globally.

SCOPE OF STUDY:

The report analyzes the Cartilage Degeneration Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Knee, Hip, Other Applications); Type (Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation, Other Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • AlloSource
  • Anika Therapeutics, Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • Ed. Geistlich Sohne AG (Geistlich Group)
  • Huntington Hospital
  • J&J MedTech
  • Smith & Nephew Plc
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Cartilage Degeneration Therapy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Osteoarthritis and Age-Related Joint Disorders
    • Growing Adoption of Regenerative Medicine for Cartilage Degeneration Treatment
    • Technological Advancements in Stem Cell and Platelet-Rich Plasma (PRP) Therapies
    • Rising Demand for Minimally Invasive Cartilage Repair Solutions
    • Expansion of Sports Medicine Driving Demand for Cartilage Restoration Therapies
    • Technological Innovations in Tissue Engineering and Cartilage Scaffolds
    • Increasing Focus on Delaying or Preventing Joint Replacement Surgeries
    • Growing Awareness of Autologous Therapies for Cartilage Repair and Regeneration
    • Rising Adoption of Biologics and Cell-Based Therapies in Orthopedic Care
    • Expansion of Research and Clinical Trials for Advanced Cartilage Degeneration Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cartilage Degeneration Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cartilage Degeneration Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Joint Replacements by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Joint Replacements by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chondroplasty by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chondroplasty by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Osteochondral Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Osteochondral Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Microfracture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Microfracture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Meniscus Transplants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Meniscus Transplants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cell based Cartilage Resurfacing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cell based Cartilage Resurfacing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Autologus Chondrocyte Implantation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Autologus Chondrocyte Implantation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Knee by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Knee by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Hip by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Hip by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: China 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Cartilage Degeneration Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Europe 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 71: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: France 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Germany 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Italy Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Italy 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 89: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: UK Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: UK Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: UK 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cartilage Degeneration Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Cartilage Degeneration Therapy by Type - Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Cartilage Degeneration Therapy by Type - Percentage Breakdown of Value Sales for Joint Replacements, Chondroplasty, Osteochondral Transplants, Microfracture, Meniscus Transplants, Cell based Cartilage Resurfacing, Autologus Chondrocyte Implantation and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: Rest of World Recent Past, Current & Future Analysis for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of World Historic Review for Cartilage Degeneration Therapy by Application - Knee, Hip and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Rest of World 15-Year Perspective for Cartilage Degeneration Therapy by Application - Percentage Breakdown of Value Sales for Knee, Hip and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION